SCHEMBL10067955

SCHEMBL10067955

CCNc1ccc(CC(=O)O)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 4/20 0.57
ALDH1A1 P00352 2/20 0.53
HSD17B10 Q99714 2/20 0.53
HPGD P15428 1/20 0.53
SMN1; SMN2 Q16637 3/20 0.53
RAB9A P51151 1/20 0.53
GFER P55789 1/20 0.53
CA2 P00918 1/20 0.52
CAMK2A Q9UQM7 1/20 0.52
MEN1 O00255 2/20 0.51
KMT2A Q03164 2/20 0.51
KDM4E B2RXH2 2/20 0.51
POLB P06746 1/20 0.51
AKR1B1 P15121 1/20 0.50
NR1H4 Q96RI1 2/20 0.49
LMNA P02545 2/20 0.48
GAA P10253 2/20 0.48
ABCC4 O15439 1/20 0.48
TSHR P16473 1/20 0.48
PTGS1 P23219 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL11466073 0.98 FFAR1 (0.56) FFAR1ALDH1A1HSD17B10HPGDSMN1; SMN2
SCHEMBL11038206 0.85 ALDH1A1 (0.55) FFAR1ALDH1A1HSD17B10HPGDSMN1; SMN2
SCHEMBL13768114 0.84 POLB (0.50) FFAR1ALDH1A1HSD17B10HPGDSMN1; SMN2
SCHEMBL25121838 0.82 MAPT (0.43) FFAR1ALDH1A1HSD17B10HPGDSMN1; SMN2
SCHEMBL15075268 0.82 MAPT (0.43) FFAR1ALDH1A1HSD17B10HPGDSMN1; SMN2
SCHEMBL8068242 0.82 CA2 (0.53) CA2LMNA
SCHEMBL5458094 0.82 ALDH1A1 (0.61) FFAR1ALDH1A1HSD17B10HPGDSMN1; SMN2
SCHEMBL13611310 0.82 FFAR1 (0.59) FFAR1ALDH1A1HSD17B10HPGDSMN1; SMN2
SCHEMBL9781961 0.81 FFAR1 (0.54) FFAR1ALDH1A1HSD17B10HPGDSMN1; SMN2
Oxalic Acid SCHEMBL9716123 0.81 LMNA (0.55) FFAR1ALDH1A1HPGDSMN1; SMN2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120077711-A1 Novel Ligands and Libraries of Ligands SUNESIS PHARMACEUTICALS, INC. (US) 2012-03-29 US disclosed
US-8138361-B2 C-10 carbamates of taxanes THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2012-03-20 US disclosed
US-20090306014-A1 C-10 CARBAMATES OF TAXANES ACIDOPHIL LLC (US) 2009-12-10 US disclosed
US-3957850-A ANALGESICS, ANTIINFLAMMATORY AGENTS BOUCHARA EMILE 1976-05-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090306014-A1 C-10 CARBAMATES OF TAXANES CASP10, S100A10, ATXN10 FFAR1 4224/4885ALDH1A1 1408/4885HSD17B10 781/4885
US-20120077711-A1 Novel Ligands and Libraries of Ligands LSS, ABCG2, SELL FFAR1 302/4885ALDH1A1 533/4885HSD17B10 2891/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.